Dr. Thomas Allan Stewart Jr., MD

Dr. Stewart practices at Enloe Health in Chico, California, part of Enloe Health.

Dr. Stewart's NPI, 1558576371, was assigned on May 14, 2007. Dr. Stewart graduated from Loma Linda University School Of Medicine in 2005. Dr. Stewart holds California license A97950.

Dr. Stewart's primary practice is Enloe Health, at 1531 Esplanade, Chico, CA 95926 in Butte County. The practice phone is (530) 332-7300.

Dr. Stewart's primary practice is Enloe Health in Chico, California, part of Enloe Health. Dr. Stewart is also affiliated with Oroville Hospital. The medical group on file is Chico Hospitalist Group. Dmand AI also links Dr. Stewart to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stewart practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Stewart's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Stewart is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Stewart is licensed in California.

Dmand AI lists acute sinusitis, chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery and hearing loss and impairment among the conditions Dr. Stewart treats.

CMS data shows 1,677 Medicare services from Dr. Stewart across 11 procedure codes in 2024, for 780 Medicare patients. Medicare paid $88,793 for them. Every service was in an office.

CMS counts 780 Medicare patients who saw Dr. Stewart in 2024. The largest group is 65 to 74, with 320 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 19% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Stewart's median patient age at 73, with 55% women.

In 2024, Dr. Stewart wrote 940 Medicare Part D claims for 309 patients. 97% of them were for generic drugs. CMS names the drug for 850 of them, across 14 drugs with 11 or more claims each, at $29,893 in total drug cost. In 2023, CMS named 771 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Stewart for performance year 2024, reported as part of a group. Dr. Stewart accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Stewart as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Stewart. Dr. Stewart's most frequent co-authors are Cody Sheridan Carter, MD and Kristin Ann Seiberling, MD.

CMS Open Payments shows 1 general payment to Dr. Stewart from 1 drug or device company in 2018. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $89.

Dr. Stewart graduated from Loma Linda University School Of Medicine in 2005.

Dr. Stewart is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.